Plant-produced recombinant Osteopontin-Fc fusion protein enhanced osteogenesis

Stadtfeld, 2008, Reprogramming of pancreatic beta cells into induced pluripotent stem cells, Curr. Biol., 18, 890, 10.1016/j.cub.2008.05.010 Shrivats, 2014, Bone tissue engineering: state of the union, Drug Discov. Today, 19, 781, 10.1016/j.drudis.2014.04.010 Lee, 2007, Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering, Adv. Drug Deliv. Rev., 59, 339, 10.1016/j.addr.2007.03.016 Nillesen, 2007, Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF, Biomaterials, 28, 1123, 10.1016/j.biomaterials.2006.10.029 Cummings, 2014, Vaccine, 32, 2251, 10.1016/j.vaccine.2013.10.017 Phoolcharoen, 2011, Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana, Plant Biotechnol. J., 9, 807, 10.1111/j.1467-7652.2011.00593.x Olinger, 2012, Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques, Proc. Natl. Acad. Sci. U. S. A., 109, 18030, 10.1073/pnas.1213709109 Rattanapisit, 2017, Recombinant human osteopontin expressed in Nicotiana benthamiana stimulates osteogenesis related genes in human periodontal ligament cells, Sci. Rep., 7, 17358, 10.1038/s41598-017-17666-7 Young, 2015, Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A, J. Thromb. Haemost., 13, 967, 10.1111/jth.12911 Sockolosky, 2014, Fusion of a short peptide that binds immunoglobulin G to a recombinant protein substantially increases its plasma half-life in mice, PLoS One, 9, 10.1371/journal.pone.0102566 Lu, 2012, Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants, J. Biomed. Biotechnol., 2012, 10.1155/2012/364240 Dumont, 2012, Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs, Blood, 119, 3024, 10.1182/blood-2011-08-367813 Gan, 2015, GLP-1-Exendin-4/IgG4 (Fc) fusion protein as a novel drug for diabetes treatment, Exp. Clin. Endocrinol. Diabetes, 123, 371, 10.1055/s-0035-1548797 Yu, 2013, Immunoglobulin Fc domain fusion to apolipoprotein(a) kringle V significantly prolongs plasma half-life without affecting its anti-angiogenic activity, Protein Eng. Des. Sel., 26, 425, 10.1093/protein/gzt015 Wang, 2014, Immunoglobulin Fc domain fusion to TRAIL significantly prolongs its plasma half-life and enhances its antitumor activity, Mol. Cancer Ther., 13, 643, 10.1158/1535-7163.MCT-13-0645 Knauf, 1988, Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers, J. Biol. Chem., 263, 15064, 10.1016/S0021-9258(18)68146-3 Shapiro, 2012, Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients, Blood, 119, 666, 10.1182/blood-2011-07-367003 Tuettenberg, 2012, Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients, Int. Immunopharmacol., 13, 93, 10.1016/j.intimp.2012.03.004 Moreland, 1997, Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein, N. Engl. J. Med., 337, 141, 10.1056/NEJM199707173370301 Huang, 2010, High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system, Biotechnol. Bioeng., 106, 9 Huang, 2009, A DNA replicon system for rapid high-level production of virus-like particles in plants, Biotechnol. Bioeng., 103, 706, 10.1002/bit.22299 Li, 2002, Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters, Sheng wu gong cheng xue bao, 18, 424 McCaw, 2014, Evaluation of a novel methacrylate-based Protein A resin for the purification of immunoglobulins and Fc-fusion proteins, Biotechnol. Prog., 30, 1125, 10.1002/btpr.1951 Huang, 2009, Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology, Curr. Opin. Biotechnol., 20, 692, 10.1016/j.copbio.2009.10.010 Jafari, 2017, Fc-fusion proteins in therapy: an updated view, Curr. Med. Chem., 24, 1228, 10.2174/0929867324666170113112759 Chen, 2011, Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants, Hum. Vaccin., 7, 331, 10.4161/hv.7.3.14262 Kim, 2018, Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties, Plant Biotechnol. J., 16, 1283, 10.1111/pbi.12869 Soleimanpour, 2015, APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice, Appl. Microbiol. Biotechnol., 99, 10467, 10.1007/s00253-015-6952-z Zhao, 2018, Immunization with Fc-based recombinant epstein-barr virus gp350 elicits potent neutralizing humoral immune response in a BALB/c mice model, Front. Immunol., 9, 932, 10.3389/fimmu.2018.00932 Osathanon, 2013, Surface-bound oriented Jagged-1 enhances osteogenic differentiation of human periodontal ligament-derived mesenchymal stem cells, J. Biomed. Mater. Res. A, 101, 358, 10.1002/jbm.a.34332